CN Patent

CN107224438B — 富马酸沃诺拉赞药物组合物

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2021-04-06 · 5y expired

What this patent protects

本发明涉及富马酸沃诺拉赞药物组合物，提供了一种含有活性成分富马酸沃诺拉赞的药物组合物和使其稳定的方法。具体而言，本发明含有富马酸沃诺拉赞的药物组合物不含增塑剂，具有良好的制剂稳定性，在高温环境和光照期间均具有良好的稳定性。

USPTO Abstract

本发明涉及富马酸沃诺拉赞药物组合物，提供了一种含有活性成分富马酸沃诺拉赞的药物组合物和使其稳定的方法。具体而言，本发明含有富马酸沃诺拉赞的药物组合物不含增塑剂，具有良好的制剂稳定性，在高温环境和光照期间均具有良好的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN107224438B
Jurisdiction
CN
Classification
—
Expires
2021-04-06
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.